Article
Targeting Insulin Receptor with a Novel Internalizing Aptamer
1 Jan 2016
Abstract excerpt
Nucleic acid-based aptamers are emerging as therapeutic antagonists of disease-associated proteins such as receptor tyrosine kinases. They are selected by an in vitro combinatorial chemistry approach, named Systematic Evolution of Ligands by Exponential enrichment (SELEX), and thanks to their small size and unique chemical characteristics, they possess several advantages over antibodies as diagnostics and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
